Two of the most popular brands are Ancestry and 23andMe. To learn more, we outlined the pros, cons and factors to consider. However, since this comparison was first published, 23andMe has ...

Biotech company 23andMe had a rough 2024, including a $30 million settlement payment after customer data was compromised.

A while back, we rounded up a bunch of horror stories from people's experiences with DNA tests like 23andMe. And, it turns ...

23andMe CEO Anne Wojcicki sounded optimistic about the company's future during an earnings call in February last year. She said the biotech company, which offers direct-to-consumer genetic testing ...

But there are facts, law and precedent on point, which are worth examining. First, we can start with 23andMe’s privacy statement, which is—to their credit—strong. In general, data can be ...

The struggling genetic-testing company 23andMe has been quietly exploring a possible sale of its telehealth offering, Business Insider has learned. 23andMe has been testing the waters for a buyer ...

A while back, we rounded up a bunch of horror stories from people's experiences with DNA tests like 23andMe. And, it turns out, a lot of people wanted to share their similarly shocking stories.

23andMe, born from the techno-optimism of the Human Genome Project, revolutionized direct-to-consumer genetic testing. But with its valuation now in freefall, mounting layoffs and its board ...

23andMe faced major hurdles in 2024, including a $30 million settlement related to compromised data. 23andMe is now restructuring its business operations to reduce costs and streamline operations.

Investing.com -- 据Business Insider报道，基因检测公司23andMe正在考虑出售其远程医疗部门Lemonaid Health。该公司目前面临财务困难，最初于2021年以4亿美元的现金加股票交易收购了这家虚拟医疗初创公司。 在2023年发生的一起数据泄露事件暴露了众多客户账户后，23andMe的股票价值出现了显著下跌。出售Lemonaid ...